BIO-UV Group S.A. manufactures and markets ultraviolet light water treatment equipment for individuals and professionals in France.
High growth potential with mediocre balance sheet.
Share Price & News
How has BIO-UV Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ALTUV has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ALTUV exceeded the French Machinery industry which returned -6.6% over the past year.
Return vs Market: ALTUV exceeded the French Market which returned 16.6% over the past year.
Price Volatility Vs. Market
How volatile is BIO-UV Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StInvestors Who Bought BIO-UV Group (EPA:ALTUV) Shares A Year Ago Are Now Up 25%
1 month ago | Simply Wall StIs BIO-UV Group (EPA:ALTUV) Weighed On By Its Debt Load?
2 months ago | Simply Wall StDo Insiders Own Shares In BIO-UV Group S.A. (EPA:ALTUV)?
Is BIO-UV Group undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: ALTUV (€3.58) is trading above our estimate of fair value (€3.13)
Significantly Below Fair Value: ALTUV is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ALTUV is unprofitable, so we can't compare its PE Ratio to the Machinery industry average.
PE vs Market: ALTUV is unprofitable, so we can't compare its PE Ratio to the French market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ALTUV's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ALTUV is overvalued based on its PB Ratio (1.7x) compared to the FR Machinery industry average (1.4x).
How is BIO-UV Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALTUV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: ALTUV is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALTUV's is expected to become profitable in the next 3 years.
Revenue vs Market: ALTUV's revenue (40% per year) is forecast to grow faster than the French market (4.6% per year).
High Growth Revenue: ALTUV's revenue (40% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALTUV's Return on Equity is forecast to be low in 3 years time (14%).
How has BIO-UV Group performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: ALTUV has a high level of non-cash earnings.
Growing Profit Margin: ALTUV's current net profit margins (-0.7%) are lower than last year (-0.2%).
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ALTUV's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ALTUV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ALTUV is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (-20.2%).
Return on Equity
High ROE: ALTUV has a negative Return on Equity (-0.67%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
How is BIO-UV Group's financial position?
Financial Position Analysis
Short Term Liabilities: ALTUV's short term assets (€14.5M) exceeds its short term liabilities (€6.2M)
Long Term Liabilities: ALTUV's short term assets (14.5M) exceeds its long term liabilities (6.1M)
Debt to Equity History and Analysis
Debt Level: ALTUV's debt to equity ratio (25%) is considered satisfactory
Reducing Debt: Insufficient data to determine if ALTUV's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: ALTUV's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if ALTUV's interest payments on its debt are well covered by EBIT.
Inventory Level: ALTUV has a high level of physical assets or inventory.
Debt Coverage by Assets: ALTUV's debt is covered by short term assets (assets are 3.5x debt).
What is BIO-UV Group's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate ALTUV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ALTUV's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ALTUV's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ALTUV's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ALTUV's dividend in 3 years as they are not forecast to pay a notable one for the French market.
What is the CEO of BIO-UV Group's salary, the management and board of directors tenure and is there insider trading?
BIO-UV Group has no CEO, or we have no data on them.
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 60%.
MD & Chairman
- Tenure: 0yrs
- Tenure: 0yrs
- Tenure: 0yrs
BIO-UV Group S.A.'s company bio, employee growth, exchange listings and data sources
- Name: BIO-UV Group S.A.
- Ticker: ALTUV
- Exchange: ENXTPA
- Founded: 2000
- Industry: Industrial Machinery
- Sector: Capital Goods
- Market Cap: €28.060m
- Shares outstanding: 7.84m
- Website: https://www.bio-uv.com
Number of Employees
- BIO-UV Group S.A.
- 850 avenue Louis Medard
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ALTUV||ENXTPA (Euronext Paris)||Yes||Common Shares||FR||EUR||Jul 2018|
BIO-UV Group S.A. manufactures and markets ultraviolet light water treatment equipment for individuals and professionals in France. Its products are used in various applications, including automatic water ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2019/11/16 22:47|
|End of Day Share Price||2019/11/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.